Long Shen Rong issued: Controlled subsidiaries obtained the "On-site Inspection and Registration Documents of the First Batch of Products Before Drug Listing"

Long Shenrong announced that its holding subsidiary, Gansu Puan Pharmaceutical, has obtained the "On-site Inspection and First Batch Product Inspection Registration Document Before Drug Listing" issued by the Gansu Provincial Drug Administration. The drug is named Tongmai Oral Liquid, with the drug approval number of National Drug Approval Z20093180, specifications of 10ml per bottle, and a shelf life of 18 months. The drug's main function is to promote blood circulation and treat ischemic cardiovascular and cerebrovascular diseases, arteriosclerosis, cerebral thrombosis, cerebral ischemia, coronary heart disease, and angina pectoris. Obtaining the "On-site Inspection and First Batch Product Inspection Registration Document Before Drug Listing" marks the formal qualification of Tongmai Oral Liquid for sales.